Login / Signup

Using Phase-Based Costing of Real-World Data to Inform Decision-Analytic Models for Atrial Fibrillation.

Amy TawfikWalter P WodchisPetros PechlivanoglouJeffrey HochDonald HusereauMurray Krahn
Published in: Applied health economics and health policy (2017)
Real-world Canadian data and a phase-based costing approach were used to estimate short- and long-term costs associated with AF-related major clinical events. The results of this study can also inform decision-analytic models for AF.
Keyphrases
  • atrial fibrillation
  • electronic health record
  • oral anticoagulants
  • catheter ablation
  • left atrial
  • big data
  • left atrial appendage
  • decision making
  • direct oral anticoagulants
  • heart failure
  • left ventricular